* Pharvaris BV PHVS.OQ reported a quarterly adjusted loss
of 66 cents per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 38 cents per share.
* Reported revenue was zero; analysts expected zero.
* Pharvaris BV's reported EPS for the quarter was a loss of 66
cents.
* In the last 30 days two analysts negatively revised earnings
estimates
* Pharvaris BV shares had fallen by 27.6% this quarter.
* The company reported a quarterly loss of €6.04 million.
* Wall Street's median 12-month price target for Pharvaris BV is
$48.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated May 28 at 03:24 p.m. GMT.
All figures in euros